General Information of the Compound
Compound ID
CP0419193
Compound Name
4-(Benzylamino)quinazoline deriv. 26
    Show/Hide
Structure
Formula
C15H12N4O2
Molecular Weight
280.287
Canonical SMILES
[O-][N+](=O)c1cccc2ncnc(NCc3ccccc3)c12
    Show/Hide
InChI
InChI=1S/C15H12N4O2/c20-19(21)13-8-4-7-12-14(13)15(18-10-17-12)16-9-11-5-2-1-3-6-11/h1-8,10H,9H2,(H,16,17,18)
    Show/Hide
InChIKey
VYDBASPMDRHHCU-UHFFFAOYSA-N
Physicochemical Property
logP
3.1501
Rotatable Bonds
4
Heavy Atom Count
21
Polar Areas
80.95
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Complexity
21

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 5328024
SID: 14972849
ChEMBL ID
CHEMBL119708
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00922, Epidermal growth factor receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000052 A-431 Homo sapiens (Human)  1
1
IC50 = 8000 nM
   TI
   LI
   LO
   TS